BioVentrix: Funding, Investors & Team (Oct 2026)
BioVentrix is a medical device company focusing on the treatment of congestive heart failure. Its mission is to improve and expand the treatment available for congestive heart failure (CHF) caused by ischemic cardiomyopathy through less invasive, catheter-based approaches.
BioVentrix has raised $56.2M across 4 funding rounds on record, the most recent an undisclosed round of $710k announced in Apr 2026.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BioVentrix Company Profile and Key Stats
Latest funding round on record: Apr 2026.
BioVentrix Funding Rounds
BioVentrix raised $6.0M in an undisclosed round announced in Jan 2022.
3 months later, an undisclosed round of $1.0M was announced in Apr 2022.
1 years later, a Series A of $48.5M was announced in Apr 2023.
3 years later, an undisclosed round of $710k was announced in Apr 2026.
BioVentrix Founders and Leadership Team
Contact details for the BioVentrix team: 2 of 3 have an email address on file.
Start 14-day free trial →BioVentrix Funding Compared to Other Biotechnology Startups
BioVentrix's latest round of $710k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BioVentrix in Biotechnology and San Ramon
Companies Similar to BioVentrix
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
BioVentrix Funding FAQs
What does BioVentrix do?
BioVentrix is a medical device company focusing on the treatment of congestive heart failure. Its mission is to improve and expand the treatment available for congestive heart failure (CHF) caused by ischemic cardiomyopathy through less invasive, catheter-based approaches.
How much funding has BioVentrix raised?
BioVentrix has raised $56.2M across 4 rounds on record. The most recent is an undisclosed round of $710k announced in Apr 2026.
When did BioVentrix last raise funding?
BioVentrix's most recent funding round on record is an undisclosed round of $710k, announced in Apr 2026.
Who founded BioVentrix?
FundedIQ lists Arthur Bertolero (Founder), Steve Chartier (Founder) at BioVentrix.
Who is the CEO of BioVentrix?
Kenneth Miller is listed as CEO at BioVentrix.
Where is BioVentrix headquartered?
BioVentrix is based in San Ramon, California, United States.
How many employees does BioVentrix have?
BioVentrix is in the 11-50 employee band.
How does BioVentrix's funding compare to other Biotechnology startups?
BioVentrix's latest round of $710k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's BioVentrix Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BioVentrix is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.